Methods for Treating Alzheimer's Disease
AssigneeCognition Pharmaceuticals LLC
InventorsMel H. Epstein, Kjesten A. Wiig, Mark F. Bear
Life of this patent
Estimating the term…
Abstract
Cognitive impairments in humans with Alzheimer's disease are treated by administering a composition that includes an amphetamine compound. Memory, attention and executive function can be improved following administration of the amphetamine compound.
Claims11
A method of treating a cognitive impairment in a human with Alzheimer's disease, comprising the step of administering an effective amount of a composition that includes at least about 85 mole percent l-amphetamine relative to the total amphetamine content of the composition to the human.
A method of treating a cognitive impairment in a human with_Alzheimer's disease, comprising the step of administering an effective amount of a composition that includes at least about 85 mole percent l-amphetamine relative to the total amphetamine content of the composition to the human and wherein the l-amphetamine is administered at a dose of at least about a 2 mg and about a 60 mg dose per day.
A method of treating a cognitive impairment in a human with Alzheimer's disease, comprising the step of orally administering an effective amount of a composition that includes at least about 95 mole percent l-amphetamine relative to the total amphetamine content of the composition to the human and methamphetamine content of the composition is l-amphetamine and wherein the l-amphetamine is administered at a dose of at least about a 2 mg and about a 60 mg dose per day.
A method of treating a cognitive impairment in a human with Alzheimer's disease, comprising the step of orally administering an effective amount of a composition that includes at least about 95 mole percent l-amphetamine relative to the total amphetamine content of the composition to the human.
Dependencies are inferred from the claim text.